Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 1, 2010 |
| Target | Focus Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Amdipharm Mercury Co. - AMCo. |
| Sellers(s) | Mobeus Equity Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 50M GBP |
FILTER BY
Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 1 of 3 |
| Country: United Kingdom | 1 of 1 |
| Year: 2010 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-12-06 |
Abcur AB
Sweden Abcur AB is a Swedish based pharmaceutical company focusing on development, registration and marketing of specialized pharmaceutical products. Our strive is to make necessary pharmaceutical products available in the Nordic area. This is done by a close cooperation with the medical care. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2004 |
| Size | Middle-Market |
| Type | Sector Agnostic |
Mobeus Equity Partners is a generalist investor in UK-based companies. Mobeus looks to invest between £2 and £20 million in a variety of transaction situations. These include MBOs, secondary buyouts, debt financings, shareholder liquidity needs, and recapitalizations. Mobeus generally targets high growth, profitable (£1 to £5 million) businesses with sustainable competitive advantages. Mobeus is based in London.
| Deal Context for Seller | # |
|---|---|
| Overall | 11 of 50 |
| Sector: Life Science | 1 of 1 |
| Type: Add-on Acquisition | 6 of 27 |
| Country: United Kingdom | 11 of 49 |
| Year: 2010 | 3 of 3 |
| Size (of disclosed) | 3 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-01 |
SEC Life Sciences
London, United Kingdom SEC Life Sciences is a specialist recruitment and resourcing service provider to a wide range of customers throughout Europe. SEC Life Sciences was founded in 1992 and is based in London, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-21 |
Bourn Hall Clinic
Cambridge, United Kingdom Bourn Bioscience Ltd. is an independent fertility provider that offers fertility treatments to self-funding and NHS patients in our clinics in Cambridge, Colchester, Norwich, King's Lynn, Peterborough, and Wickford. Bourn Bioscience was established in 1980 and is based in Cambridge, United Kingdom. |
Buy | - |
